The Liberals and the New Democrats full-throatedly pledged to stop the Conservatives from blocking their pharmacare legislation in the House of Commons on Monday — even though the two parties have more than enough votes to bypass the Opposition.
Alberta Premier Danielle Smith has introduced legislation to gatekeep and if necessary veto any future deal struck between municipalities and the federal government.
The parliamentary budget officer is projecting inflation will return to the Bank of Canada's two per cent target by the end of the year and the federal deficit will grow amid weakening economic conditions.
Singh told a town hall meeting in Edmonton, where the New Democrats are holding a caucus retreat, that dealing with the federal government is "not fun."
As Liberals and New Democrats negotiate what a future national drug plan should look like, a new survey suggests pharmacare is not at the top of the priority list for most Canadians.
Government House leader Karina Gould warned on Tuesday the Liberals are unlikely to get a pharmacare bill passed by the end of the year, despite their promise to do so in an agreement with the NDP.
The federal New Democrats plan to make pharmacare a central issue in the next election if the Liberals do not meet the bar the opposition party has set for legislation to reduce the cost of prescription drugs.
The federal New Democrats have rejected the first draft of the Liberals' pharmacare legislation, in what the health minister describes as "extremely fluid" negotiations over the highly anticipated bill.
No longer content to wait for the Liberals to make good on their promise, the New Democrats tabled their own pharmacare legislation in the House of Commons on Tuesday, June 13, 2023.
Jagmeet Singh took a victory lap at his New Democrat caucus meeting on Wednesday, March 29, 2023, in a speech that praised his party’s wins in the recent federal budget.
British Columbia's health minister plans to announce how the government will ensure patients in the province will have secure access to the diabetes and weight loss drug Ozempic.
Big Pharma has stepped up its lobbying game ever since the federal NDP struck a deal to prop up the Liberals’ minority government contingent on several big-ticket items — including progress on national pharmacare.